Chad Prusmack
Neurological Surgery · Lone Tree, CONPI 1396844346
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $2,081,575 of the $2,089,350 with a category attached, or 99.6%. Globus Medical accounts for 100.0% of it on its own, with 8 other manufacturers making up the rest. Among neurological surgery clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $20,893 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$2.1M
- Antares Pharma, Inc.$76
- Si-bone, Inc.$65
- Boston Scientific$36
- Integrity Implants Inc.$34
- Radius Health, Inc.$26
- plus $47 from 3 others
What the payments were for
- Royalty or licence$2,081,575100%
- Speaking & faculty fees$7,1500%
- Travel & lodging$2400%
- Food & beverage$3850%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 85 | $2,089,066 |
| Antares Pharma, Inc. | 4 | $76 |
| Si-bone, Inc. | 4 | $65 |
| Boston Scientific | 1 | $36 |
| Integrity Implants Inc. | 1 | $34 |
| Radius Health, Inc. | 2 | $26 |
| Medtronic | 1 | $16 |
| AbbVie | 1 | $16 |
| Lemaitre Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SIGNIFY$767,978
- CREO$547,221
- CREO MIS Stabilization System$358,087
- REVOLVE$312,435
- KINEX$58,883
- MARS$36,971
- ALTERA$7,150
- Excelsius3D Imaging System$198
How this compares
$2,089,350 in reported general payments places this provider in the 95th percentile of 149 neurological surgery providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 48 | $30,451 |
| CreonLipase/Protease/Amylase | 12 | $13,705 |
| EliquisApixaban | 11 | $6,132 |
| Nystatin | 27 | $1,176 |
| Celecoxib | 36 | $654 |
| CholestyramineCholestyramine (With Sugar) | 19 | $543 |
| Levothyroxine Sodium | 14 | $354 |
| Hydroxychloroquine Sulfate | 13 | $326 |
| Metformin Hcl ErMetformin Hcl | 33 | $252 |
| Tamsulosin Hcl | 15 | $204 |
| Rosuvastatin Calcium | 11 | $148 |
| Potassium Chloride | 12 | $118 |
| Prednisone | 16 | $57 |
| Metoprolol Tartrate | 12 | $16 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $16 | $13,70512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 149 neurological surgery providers in Colorado.
Other neurological surgery in Lone Tree
- Bradley DuhonLone Tree$386K
- Eric AriasLone Tree$85K
- Brent KimballLone Tree$82K
- Mark RobinsonLone Tree$65K
- Sharad RajpalBoulder$2.8M
- Timothy WirtFort Collins$581K
- Donn TurnerFort Collins$581K
- Ernest BraxtonEdwards$549K
- Peter SyreEnglewood$301K
- Sean MarkeyDenver$170K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.